PT3459542T - Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal - Google Patents

Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal

Info

Publication number
PT3459542T
PT3459542T PT177996741T PT17799674T PT3459542T PT 3459542 T PT3459542 T PT 3459542T PT 177996741 T PT177996741 T PT 177996741T PT 17799674 T PT17799674 T PT 17799674T PT 3459542 T PT3459542 T PT 3459542T
Authority
PT
Portugal
Prior art keywords
preventing
trigeminal neuralgia
carbamate compound
treating trigeminal
treating
Prior art date
Application number
PT177996741T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of PT3459542T publication Critical patent/PT3459542T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT177996741T 2016-05-19 2017-05-18 Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal PT3459542T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20160061386 2016-05-19

Publications (1)

Publication Number Publication Date
PT3459542T true PT3459542T (pt) 2021-08-24

Family

ID=60325324

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177996741T PT3459542T (pt) 2016-05-19 2017-05-18 Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal

Country Status (14)

Country Link
US (1) US11207295B2 (https=)
EP (1) EP3459542B1 (https=)
JP (1) JP6960415B2 (https=)
KR (1) KR102421013B1 (https=)
CN (1) CN109310669B (https=)
AU (1) AU2017267160B2 (https=)
CA (1) CA3024284C (https=)
DK (1) DK3459542T3 (https=)
ES (1) ES2887338T3 (https=)
MX (1) MX389613B (https=)
PL (1) PL3459542T3 (https=)
PT (1) PT3459542T (https=)
RU (1) RU2751504C2 (https=)
WO (1) WO2017200317A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3556365B1 (en) * 2016-12-14 2025-07-02 SK Biopharmaceuticals Co., Ltd. Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease
ES2978226T3 (es) * 2018-09-21 2024-09-09 Sk Biopharmaceuticals Co Ltd Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático
AU2019361856B2 (en) * 2018-10-19 2024-11-07 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
IL157593A0 (en) * 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in the treatment of pain
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
JP4227121B2 (ja) 2005-06-08 2009-02-18 独立行政法人科学技術振興機構 神経因性疼痛治療剤
WO2010150946A1 (en) 2009-06-22 2010-12-29 Sk Holdings Co., Ltd. Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
CA2817290A1 (en) * 2010-11-11 2012-05-18 Josef Penninger Compounds and methods for treating pain
MX368735B (es) 2014-05-09 2019-10-14 Tecnimede Sociedade Tecnico Medicinal S (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.

Also Published As

Publication number Publication date
WO2017200317A1 (ko) 2017-11-23
RU2751504C2 (ru) 2021-07-14
CN109310669B (zh) 2022-02-22
KR102421013B1 (ko) 2022-07-14
EP3459542A4 (en) 2020-01-08
KR20170131241A (ko) 2017-11-29
US11207295B2 (en) 2021-12-28
JP6960415B2 (ja) 2021-11-05
PL3459542T3 (pl) 2021-12-27
AU2017267160A1 (en) 2018-12-13
AU2017267160B2 (en) 2022-11-10
RU2018144784A (ru) 2020-06-19
MX2018014081A (es) 2019-09-02
US20190175555A1 (en) 2019-06-13
CA3024284A1 (en) 2017-11-23
US20220087976A1 (en) 2022-03-24
DK3459542T3 (da) 2021-09-13
EP3459542B1 (en) 2021-06-30
RU2018144784A3 (https=) 2020-08-11
ES2887338T3 (es) 2021-12-22
CA3024284C (en) 2024-01-23
JP2019516722A (ja) 2019-06-20
MX389613B (es) 2025-03-20
EP3459542A1 (en) 2019-03-27
BR112018073556A2 (pt) 2019-03-19
CN109310669A (zh) 2019-02-05

Similar Documents

Publication Publication Date Title
IL321844A (en) Menin–MLL interaction inhibitors
GB2555517B (en) Mitigation of return-oriented programming attacks
PL3109223T3 (pl) Mieszanina do obróbki nawozów zawierających mocznik
PL3512850T3 (pl) Inhibitory interakcji menina-mll
PL3436444T3 (pl) Związek heterocykliczny
PT3348557T (pt) Imidazo[1,2a]piridinas para o tratamento ou prevenção de hiperuricemia ou gota
IL267199A (en) A method for treating epilepsy
SG11201708793SA (en) Crystals of azabicyclic compound
IL257908A (en) Methods for the treatment of epilepsy
PL3459543T3 (pl) Związek karbaminianowy do zapobiegania lub leczenia fibromialgii
ZA201704116B (en) 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase
IL256109A (en) Methods for the treatment or prevention of protopathy
ZA202103106B (en) Heterocyclic compounds for the treatment of epilepsy
SI3661510T1 (sl) Postopki zdravljenja vedenjskih sprememb
PL3459542T3 (pl) Zastosowanie związku karbaminianu do zapobiegania lub leczenia neuralgii nerwu trójdzielnego
SI3424930T1 (sl) Kristal spojine z učinkovitostjo zaviranja JAK
IL274979A (en) Methods for the prevention and treatment of neurogenic seizures
IL262916A (en) Treatment of side effects resulting from chemo-nervous disorder
IL274084A (en) Comb for the treatment of dandruff
PT3097082T (pt) Processos para a síntese de composto de ureia substituída
PT3661510T (pt) Métodos de tratamento de alterações do comportamento
GB201701928D0 (en) Compounds for the treatment of hyperglycaemia